In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures The Washington Post FDA's Legislative Request on Rx and Compounded Drug Advertising Coalition for Healthcare Communication RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion